Published

The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychiatry research
Date: 2020-02-01
Source: PubMed
DOI: 10.1016/j.psychres.2020.112749
PubMed: 31931272

Authors

Goldberg SB Pace BT Nicholas CR Raison CL Hutson PR

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Meta-Analysis Safety Adverse Events Meta-Analysis

Citation graph

0 referenced DOIs found in stored source metadata. 11 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Longitudinal neural and psychological changes following psilocybin under compassion imagery priming2026-07-22 Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions2026-07-02 Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms2026-07-01 Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase development2026-06-01 Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial2026-06-01 Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey2026-04-15 Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications2026-04-01 Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis2026-04-01 “Diversity makes the richness of humanity”: The emergence and persistence of mental imagery after self-reported psilocybin truffles intake in an autistic woman with “blind imagination” (aphantasia): A33-month retrospective case report2026-03-09 Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy2026-03-01 In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin2024-01-08

Related papers

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07 Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06 A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and DepressionClinicalTrials.gov · 2026-07-31 Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01 Balancing safety and access in Oregon’s psilocybin servicesInternational Journal of Drug Policy · 2026-09-01 Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer CareUnknown journal · 2026-08-17 The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14